Immunological effects of recombinant feline interferon-ω (KT-80) administration in the dog

Microbiology and Immunology

Volumn 50, Issue 8, 2006, Pages 637-641

  Kuwabara, Masato ^a   Nariai, Youko ^a   Horiuchi, Yutaka ^a   Nakajima, Yuko ^a   Yamaguchi, Yu ^a   Horioka, Eriko ^a   Kawanabe, Mikiko ^a   Kubo, Takuya ^b   Yukawa, Masayoshi ^a   Sakai, Takeo ^a  

^a NIHON UNIVERSITY   (Japan)

^b Hokuai Animal Hospital   (Japan)

Author keywords

CPV; Dog; KT 80; rFeIFN

Indexed keywords

INTERFERON; KT 80; RECOMBINANT FELINE INTERFERON OMEGA; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CELLULAR IMMUNITY; IMMUNOREACTIVITY; MACROPHAGE; NATURAL KILLER T CELL; PARVOVIRUS; PARVOVIRUS INFECTION; PERIPHERAL LYMPHOCYTE; WHOLE CELL;

CANINE PARVOVIRUS; CANIS FAMILIARIS; FELIDAE;

EID: 33747849280     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03828.x     Document Type: Article

References (17)

1. Adolf, G.R. 1995. Human interferon omega - a review. Mult. Scler. 1: 44-47.
2. Ishiwata, K., Minagawa, T., and Kajimoto, T. 1998. Clinical effects of the recombinant feline interferon-ω on experimental parvovirus infection in beagle dogs. J. Vet. Med. Sci. 60: 911-917.
3. Kosaka, T., Koide, F., Kuwabara, M., and Tanaka, S. 1990. Effect of radical scavengers on canine peripheral blood mononuclear lymphocyte-mediated cytotoxicity and production of active oxygen. J. Vet. Sci. 52: 1043-1048.
4. Kramer, J.M., Meunier, P.C., and Pollock, R.V. 1980. Canine parvovirus: update. Vet. Med. Small Anim. Clin. 75: 1541-1555.
5. Kubes, M., Fuchsberger, N., and Kontsek, P. 1994. Cross-species antiviral and antiproliferative activity of human interferon-omega. J. Interferon Res. 14: 57-59.
6. Martin, V., Najbar, W., Gueguen, S., Grousson, D., Eun, H.M., Lebreux, B., and Aubert, A. 2002. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet. Microbiol. 89: 115-127.
7. Minagawa, T., Ishiwata, K., and Kajimoto, T. 1999. Feline interferon-ω treatment on canine parvovirus infection. Vet. Microbiol. 69: 51-53.
8. Mochizuki, M., Nakatani, H., and Yoshida, M. 1994. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet. Microbiol. 39: 145-152.
9. Nakada, Y., Kosaka, T., Kuwabara, M., Tanaka, S., Sato, K., and Koide, F. 1993. Effect of 2-carboxythylgerumanium sesquioxide (Ge-132) as an immunological modifier of post surgical immunosuppression in dogs. J. Vet. Med. Sci. 55: 795-799.
10. Nakada, Y., Tokumitu, K., Kosaka, T., Kuwabara, M., Tanaka, S., and Koide, F. 1995. Correlation between canine NK cell mediated cytotoxicity and radical production. Vet. Immunol. Immunopathol. 45: 285-295.
11. Parrish, C.R. 1990. Emergence, natural history, and variation of canine, mink, and feline parvoviruses. Adv. Virus Res. 38: 403-450.
12. Pestka, S., Langer, J.A., Zoon, K.C., and Samuel, C.E. 1987. Interferons and their actions. Annu. Rev. Biochem. 56: 727-777.
13. Sakurai, T., Ueda, Y., Sato, M., and Yanai, A. 1992. Feline interferon production in silkworm by recombinant baculovirus. J. Vet. Med. Sci. 54: 563-565.
14. Sen, G.C., and Lengyel, P. 1992. The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267: 5017-5020.
15. Shimoda, T., Uchino, T., Yamane, Y., and Motoyoshi, S. 1998. Comparative clinical field trials of feline interferon-ω (omega) on canine parvovirus infection. J. Anim. Clin. Med. 7: 7-15 (in Japanese).
16. Tateyama, S., Prisoeryanyo, B.P., Yamaguchi, R., and Uchida, K. 1995. In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumors. Res. Vet. Sci. 59: 275-277.
17. Ueda, Y., Sakurai, T., and Yanai, A. 1993. Homogeneous production of feline interferon in silkworm by replacing single amino acid code in signal peptide region in recombinant baculovirus and characterization of the product. J. Vet. Med. Sci. 55: 251-258.